All Updates

All Updates

icon
Filter
Earnings/results
Magnite’s topline revenue growth slows; continues to maintain momentum in CTV revenue in Q3 2022
Marketing Automation
Nov 9, 2022
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Dec 20, 2024
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Funding
Partnerships
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Marketing Automation

Marketing Automation

Nov 9, 2022

Magnite’s topline revenue growth slows; continues to maintain momentum in CTV revenue in Q3 2022

Earnings/results

  • Magnite, a leading independent supply-side ad platform (SSP), reported second-quarter financial performance for 2022 (Q3 2022). The firm achieved revenue ex-TAC (excluding acquisition costs) of USD 127.7 million (12% YoY growth) for Q2 2022, which was marginally above the upper bound of the company guidance and 2.9% above analyst estimates. Growth in demand for connected TV (CTV) continued to support topline performance, which grew by 29% YoY and accounted for an increasing share of ex-TAC revenue (Q3 2022: ~44%; Q2 2022: 42%; Q1 2022: 40%). 

  • The firm recorded an adjusted EBITDA of USD 44.4 million (11% YoY growth) during Q3 2022, which represents an adjusted EBITDA margin of 35% in line with the margin for Q3 2021. The improved EBITDA was attributed to lower-than-expected operating expenses due to a reduction in hiring and lower office and facility costs. The firm recorded a  net loss of USD 24.4 million in Q3 2022 (compared to a net loss of USD 24.3 million in Q3 2021) which corresponds to a diluted loss per share of USD 0.18, which was above analyst estimates of a loss per share of USD 0,15. 

  • For the fourth quarter of 2022 (Q4 2022E), the firm expects to achieve a revenue ex-TAC between USD 151 million and USD 157 million and for CTV revenue to be between USD 63 million and USD 65 million. The firm also expects to achieve an ex-TAC revenue above USD 510 million for the full year 2022E.

  • Analyst Quicktake: While the firm’s ex-TAC revenue has slowed compared to the previous quarter (7% QoQ dip), it is noteworthy that CTV revenue had risen over the same period (7% YoY growth). Hence the firm’s continued focus on the CTV space such as the recent partnership with rlaxx TV (an ad-based video-on-demand solution) is likely to continue to support its growth for the remainder of 2022E.  

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.